First preliminary results of an observation of Ginkgo Biloba treating patients with autistic disorder

Phytotherapy Research

Volumn 23, Issue 11, 2009, Pages 1645-1646

  Niederhofer, Helmut ^a  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

Autism; Ginkgo Biloba; Psychopharmacological treatment

Indexed keywords

CLONIDINE; GINKGO BILOBA EXTRACT; METHYLPHENIDATE; NEUROLEPTIC AGENT;

ARTICLE; AUTISM; GINKGO BILOBA; HUMAN;

AUTISTIC DISORDER; GINKGO BILOBA; HUMANS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; YOUNG ADULT;

GINKGO BILOBA;

EID: 70350482555     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2778     Document Type: Article

References (16)

1. Akhondzadeh S, Tajdar H, Mohammadi M, Nouroozinejad GH, Shabstari OL, Ghelichnia HA. 2007. Double-blind controlled trial of piracetam added to risperidone in patients with autistic disorder. Child Psychiatry Hum Dev 27: 346-357. (Pubitemid 351839896)
2. Aman MG, Singh NN, Stewart AW, Field CJ. 1985. Psychometric characteristics of the Aberrant Behavior Checklist. Am J Ment Def 99: 492-502.
3. Birmaher B, Quintana H, Greenhill LL. 1988. Methylphenidate treatment of hyperactive autistic children. J Am Acad Child Adolesc Psychiatry 27: 248-251. (Pubitemid 18089217)
4. Campbell M, Adams P, Perry R, Speneer RK, Overall JE. 1985. Tardive and withdrawal dyskinesia in autistic children: a prospective study. Psychopharmacol Bull 24: 251-255.
5. Carlson JJ, Farquhar JW, DiNucci E et al. 2007. Safety and efficacy of a Ginkgo Biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitive intact older adults. J Am Diet Assoc 107: 422-432. (Pubitemid 46281825)
6. Hunt R, Minderaa R, Cohen D. 1955. Clonidine benefits children with attention deficit disorder and hyperactivity: report of double blind placebo crossover therapeutic trial. J Am Acad Child Psychiatry 24: 617-629.
7. Itil TM, Eralp E, Ahmed I, Kunitz A, Itil KZ. 1998. The pharmacological effects of Ginkgo Biloba, a plant extract, on the brain of dementia patients in comparison with tacrine. Psychopharmacol Bull 34: 391-397. (Pubitemid 28537965)
8. Jaselskis CA, Cook EH, Fletcher KE, Leventhal BL. 1992. Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Psychopharm 5: 322-327.
9. Lyon MR, Cline JC, Totosy de Zepetnek J, Shan JJ, Pang P, Benishin C. 2001. Effect of the herbal extract combination Panax quinquefolium and Ginkgo Biloba on attention-deficit hyperactivity disorder: a pilot study. J Psychiatry Neurosci 26: 221-228. (Pubitemid 32552178)
10. Miller LG, Freeman B. 2002. Possible subdural hematoma associated with Ginkgo Biloba. J Herb Pharmacother 2: 57-63.
11. National Institute of Mental Health. 1985. Special feature: rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull 21: 839.
12. Overall JE, Campbell M. 1988. Behavioral assessment of psychopathology in children: infantile autism. J Clin Psychol 44: 708-716. (Pubitemid 18245749)
13. Paczynski M. 1997. Piracetam: a novel therapy for autism? J Autism Dev Disord 27: 628-630.
14. Perry R, Campbell M, Adams P, Lyneh N, Speneer EK. 1959. Long-term efficacy of haloperidol in autistic children: Continuous versus discontinuous drug administration. J Am Acad Child Adolesc Psychiatry 25: 57-92.
15. Shaffer D, Gould MS, Brasic J et al. 1973. The Children's Global Assessment Scale (CGAS): adapted from Global Assessment Scale for Adults. Arch Gen Psychiatry 40: 1228-1231.
16. Zhang J, Fu S, Liu S, Mao T, Xiu R. 2000. The therapeutic effect of Ginkgo Biloba extract in SHR rats and its possible mechanisms based on cerebral microvascular flow and vasomotion. Clin Hemorheol Microcirc 23: 133-138. (Pubitemid 32274596)